Article Text

Download PDFPDF

The prognostic value of TP53 mutations in oesophageal adenocarcinoma: a systematic review and meta-analysis
  1. Oliver M Fisher1,
  2. Sarah J Lord1,2,3,
  3. Dan Falkenback1,4,
  4. Nicholas J Clemons5,6,
  5. Guy D Eslick7,
  6. Reginald V Lord1,8
  1. 1Gastroesophageal Cancer Program, St Vincent's Centre for Applied Medical Research University of New South Wales, Sydney, New South Wales, Australia
  2. 2NHMRC Clinical Trials Centre University of Sydney, Sydney, New South Wales, Australia
  3. 3Department of Epidemiology and Medical Statistics, School of Medicine, University of Notre Dame, Sydney, New South Wales, Australia
  4. 4Department of Surgery, Lund University Hospital (Skåne University Hospital) and Lund University, Lund, Sweden
  5. 5Cancer Biology and Surgical Oncology Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
  6. 6Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia
  7. 7The Whiteley-Martin Research Centre, Discipline of Surgery, The University of Sydney, Sydney, New South Wales, Australia
  8. 8Department of Surgery, School of Medicine, University of Notre Dame, Sydney, New South Wales, Australia
  1. Correspondence to Dr Oliver M Fisher, Gastroesophageal Cancer Research Group, St Vincent's Centre for Applied Medical Research, 405 Liverpool Street, Sydney NSW 2010, Australia; ofisher{at}gmx.ch

Statistics from Altmetric.com

Supplementary materials

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.